How can a cortisol level be less than 1 µg/dL in a patient taking hydrocortisone 10 mg twice daily?

How Can Cortisol Be <1 µg/dL While Taking Hydrocortisone 10 mg BID?

A cortisol level <1 µg/dL in a patient taking hydrocortisone 10 mg twice daily is expected and normal—this reflects proper timing of the blood draw (at least 24 hours after the last dose) to assess endogenous HPA axis recovery, not treatment failure.

Understanding the Clinical Context

The key to interpreting this seemingly paradoxical finding lies in when the cortisol was measured. According to the 2024 European Society of Endocrinology/Endocrine Society guidelines, morning cortisol assessment for HPA axis recovery should be performed after holding the glucocorticoid dose for at least 24 hours 1. This means:

• The patient stops their hydrocortisone for 24+ hours before the blood draw
• The measured cortisol reflects only endogenous adrenal production
• Exogenous hydrocortisone has been cleared from the system

Why This Matters Clinically

A cortisol <1 µg/dL (<27.6 nmol/L) under these testing conditions indicates profound HPA axis suppression. The guidelines specifically state that patients with very low morning cortisol levels <150 nmol/L (5 μg/dL) are very likely to have persistent adrenal insufficiency 1. Your patient's level of <1 µg/dL falls well below this threshold.

Management Algorithm

For cortisol <5 µg/dL (<150 nmol/L):

1. Continue physiologic glucocorticoid replacement (hydrocortisone 15-25 mg total daily dose) 1
2. Do not attempt further dose reduction at this time
3. Repeat morning cortisol testing in 1-6 months, depending on:
   • Duration of prior glucocorticoid therapy
   • Dose of prior therapy
   • Trajectory of previous cortisol values
4. Dynamic testing is not useful at this cortisol level 1

Common Pitfalls to Avoid

Pitfall #1: Testing While Still Taking Hydrocortisone

If cortisol was measured while the patient was actively taking hydrocortisone (without the 24-hour hold), the result would be artificially suppressed because:

• Standard cortisol immunoassays cross-react with exogenous hydrocortisone
• The assay cannot distinguish between endogenous cortisol and administered hydrocortisone
• This creates a falsely low reading that doesn't reflect true adrenal function

Pitfall #2: Confusing Replacement Dose with Suppressive Dose

Hydrocortisone 20 mg daily (10 mg BID) is at the lower end of physiologic replacement (15-25 mg daily recommended) 1. This dose:

• Provides adequate glucocorticoid coverage for daily activities
• Is not a supraphysiologic dose that would necessarily suppress the HPA axis further
• Allows for potential HPA axis recovery over time
• Should not cause biochemical over-replacement

Pitfall #3: Assay-Related Issues

Several factors can affect cortisol measurement 1:

Falsely low readings occur with:

• Low albumin states (cirrhosis, nephrotic syndrome, malnutrition)
• Low cortisol-binding globulin
• Critical illness
• Different immunoassay methods (variability between labs)

Falsely high readings occur with:

• Elevated cortisol-binding globulin (pregnancy, oral estrogens)

The Pharmacokinetic Reality

Hydrocortisone has a short half-life of approximately 1.5-2 hours 2, 3. After 24 hours without dosing:

• Exogenous hydrocortisone is completely eliminated
• Only endogenous cortisol production remains measurable
• This is precisely why the 24-hour hold is required for accurate HPA axis assessment

Research demonstrates that even with optimal dosing regimens, cortisol levels fall to subphysiologic ranges within 4-6 hours after each hydrocortisone dose 4, 3. This is why:

• Three or four times daily dosing is superior to twice daily 4, 5
• Your patient on BID dosing likely experiences prolonged periods of low cortisol between doses
• The measured level <1 µg/dL after 24 hours simply represents complete clearance of exogenous hormone

Clinical Recommendations

Your patient requires:

1. Continuation of current hydrocortisone dose (or potentially slight increase to 15-25 mg total daily if currently below this range)
2. Consider switching to three or four times daily dosing to minimize hypocortisolemic periods 4, 5
3. Repeat morning cortisol in 3-6 months to assess for HPA axis recovery
4. Patient education on stress dosing and adrenal crisis prevention 6
5. Prescription for emergency injectable hydrocortisone 100 mg IM 7, 6

Do not:

• Discontinue hydrocortisone based on this result
• Perform dynamic testing at this cortisol level
• Reduce the dose further
• Assume treatment failure—this is expected glucocorticoid-induced adrenal insufficiency

The cortisol <1 µg/dL is not a treatment failure but rather confirmation that the patient has persistent HPA axis suppression requiring ongoing replacement therapy until recovery occurs.